Plunkett Research Online: Myrexis, Inc.

MYREXIS, INC. (MYRX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Myrexis Inc was incorporated as Myriad Pharmaceuticals, Inc. in Delaware in January 2009 as a new, wholly owned subsidiary of Myriad Genetics, Inc., in order to effect the separation and spin-off of Myriad Genetics' research and drug development businesses as a stand-alone, independent, publicly tra.....



Myrexis, Inc.
Ticker: MYRX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 801 214-7800
Fax: 1 801 214-7992
Address: Xstelos Holdings, Inc
630 Fifth Avenue
Suite 2260
New York, NY 10020 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Jonathan CouchmanCEO/Chairman of the Board/Director/President
Andrea KendellCFO/Chief Accounting Officer
Myrexis Inc was incorporated as Myriad Pharmaceuticals, Inc. in Delaware in January 2009 as a new, wholly owned subsidiary of Myriad Genetics, Inc., in order to effect the separation and spin-off of Myriad Genetics' research and drug development businesses as a stand-alone, independent, publicly tra.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
$USD, In whole numbers,
except marked * or %
2013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: